AT-2604

N/A

Report date: 2024/07/17 09:41:14

Base Information

Drug NameAT-2604
Drug Alias NameAT2604AT-2604
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAlkaline phosphatase, placental type modulatorsAlkaline Phosphatase, Placental Like 2 modulators
TargetsAlkaline phosphatase, placental typeAlkaline Phosphatase, Placental Like 2
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingaporeMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAxcynsis Therapeutics Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAxcynsis Therapeutics Pte Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursPancreatic NeoplasmsStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A